X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8511) 8511
Book Chapter (197) 197
Newsletter (98) 98
Newspaper Article (55) 55
Magazine Article (17) 17
Book / eBook (9) 9
Publication (5) 5
Dissertation (3) 3
Trade Publication Article (3) 3
Reference (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6008) 6008
humans (5783) 5783
life sciences & biomedicine (5440) 5440
hemic and lymphatic diseases (4449) 4449
leukemia (3157) 3157
male (2602) 2602
hematology (2574) 2574
oncology (2439) 2439
female (2385) 2385
chronic lymphatic leukemia (2075) 2075
middle aged (2074) 2074
aged (1892) 1892
chronic lymphocytic leukemia (1695) 1695
chronic myeloid leukemia (1659) 1659
adult (1510) 1510
cancer (1438) 1438
lymphatic leukemia (1233) 1233
animals (1098) 1098
research (1088) 1088
leukemia, lymphocytic, chronic, b-cell - pathology (1021) 1021
patients (1005) 1005
neoplasms (925) 925
immune system diseases (918) 918
aged, 80 and over (908) 908
leukemia, lymphocytic, chronic, b-cell - genetics (897) 897
mutation (894) 894
care and treatment (874) 874
apoptosis (856) 856
lymphomas (852) 852
abridged index medicus (844) 844
leukemia, lymphocytic, chronic, b-cell - drug therapy (817) 817
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (816) 816
lymphocytes b (783) 783
medicine (765) 765
prognosis (756) 756
kinases (726) 726
leukemia, myelogenous, chronic, bcr-abl positive - genetics (718) 718
mice (718) 718
research article (692) 692
analysis (690) 690
genetic aspects (684) 684
bone marrow (650) 650
gene expression (632) 632
cell biology (631) 631
health aspects (603) 603
leukemia, myelogenous, chronic, bcr-abl positive - pathology (601) 601
proteins (596) 596
antineoplastic agents - therapeutic use (588) 588
lymphoma (583) 583
lymphocytes (579) 579
treatment outcome (571) 571
science & technology - other topics (568) 568
multidisciplinary sciences (558) 558
immunology (542) 542
imatinib mesylate (525) 525
chemotherapy (524) 524
leukemia, lymphocytic, chronic, b-cell - metabolism (521) 521
stem cells (517) 517
risk factors (513) 513
cell line, tumor (511) 511
flow cytometry (510) 510
fusion proteins, bcr-abl - genetics (507) 507
tumors (507) 507
imatinib (499) 499
leukemia, lymphocytic, chronic, b-cell - immunology (492) 492
signal transduction (489) 489
tyrosine (481) 481
myeloid leukemia (464) 464
pathology (439) 439
development and progression (430) 430
science (419) 419
adolescent (412) 412
pyrimidines - therapeutic use (412) 412
medicine, research & experimental (406) 406
antineoplastic agents - pharmacology (404) 404
drug therapy (402) 402
chronic disease (396) 396
diagnosis (395) 395
protein kinase inhibitors - therapeutic use (392) 392
medical research (391) 391
research & experimental medicine (391) 391
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (390) 390
medical prognosis (390) 390
review (373) 373
apoptosis - drug effects (370) 370
young adult (366) 366
cell proliferation (361) 361
leukemia, lymphocytic, chronic, b-cell - diagnosis (356) 356
protein-tyrosine kinase (355) 355
cll (352) 352
benzamides (351) 351
immunoglobulins (350) 350
original (349) 349
chronic lymphocytic leukaemia (348) 348
genes (346) 346
biochemistry & molecular biology (341) 341
clinical trials (337) 337
rituximab (323) 323
pyrimidines - pharmacology (318) 318
studies (317) 317
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8616) 8616
German (109) 109
Russian (73) 73
Italian (52) 52
Spanish (49) 49
Polish (31) 31
Portuguese (29) 29
French (19) 19
Japanese (18) 18
Czech (15) 15
Chinese (13) 13
Norwegian (12) 12
Danish (6) 6
Serbian (5) 5
Turkish (5) 5
Dutch (3) 3
Ukrainian (3) 3
Hebrew (2) 2
Swedish (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Croatian (1) 1
Finnish (1) 1
Hungarian (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2011, 1. Aufl., ISBN 1405196262, xxi, 416 p., [4] p. of col. plates
This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular... 
Leukemia | Lymphomas | Myelodysplastic syndromes
Book
1999, Basic and clinical oncology, ISBN 9780824799014, Volume 16., xi, 442
Book
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2018, Volume 378, Issue 12, pp. 1107 - 1120
In a trial involving patients with relapsed or refractory chronic lymphocytic leukemia, the BCL2 inhibitor venetoclax in combination with rituximab resulted in a higher 2-year rate of progression-free... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Bendamustine Hydrochloride - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Neoplasm, Residual | Young Adult | Bendamustine Hydrochloride - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Tumor Lysis Syndrome - etiology | Aged, 80 and over | Adult | Female | Neutropenia - chemically induced | Rituximab - adverse effects | Kaplan-Meier Estimate | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sulfonamides - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Sulfonamides - administration & dosage | Treatment outcome | Chronic lymphocytic leukemia | Diagnosis | Analysis | Chronic lymphatic leukemia | Cell survival | Hematology | Leukemia | Rituximab | Clinical trials | Oncology | Chromosome deletion | Lymphatic leukemia | Patients | Cancer therapies | Evidence-based medicine | Chemotherapy | Clonal deletion | Lysis | Response rates | Bone marrow | Chromosomes | Drug dosages | Chromosome 17 | Neutropenia | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2016, Volume 374, Issue 4, pp. 323 - 332
.... It had substantial antitumor effects in a phase 1–2 study involving patients with relapsed chronic lymphocytic leukemia... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Benzamides - pharmacokinetics | Humans | Middle Aged | Pyrazines - administration & dosage | Male | Antineoplastic Agents - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Antineoplastic Agents - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Benzamides - adverse effects | Headache - chemically induced | Chromosome Deletion | Protein Kinase Inhibitors - pharmacokinetics | Administration, Oral | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Agammaglobulinaemia Tyrosine Kinase | Pyrazines - pharmacokinetics | Pyrazines - adverse effects | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Treatment outcome | Usage | Care and treatment | Safety and security measures | Lymphocytic leukemia | Analysis | Clinical trials | Pharmacology | Dosage and administration | Pharmacokinetics | Antineoplastic agents | Tyrosine | Headache | Pharmacodynamics | Transformation | Chronic lymphatic leukemia | Inhibitor drugs | Leukemia | Diarrhea | Chromosome deletion | Lymphatic leukemia | Kinases | Lymphoma | Bruton's tyrosine kinase | Patients | Clonal deletion | Lymphomas | Safety | Drug therapy | Lymphocytosis | Protein-tyrosine kinase | Chromosome 17 | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2018, Volume 379, Issue 26, pp. 2517 - 2528
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2016, Volume 374, Issue 4, pp. 311 - 322
An oral inhibitor of BCL2 produces substantial responses in the majority of patients with refractory chronic lymphocytic leukemia... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Humans | Middle Aged | Male | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Antineoplastic Agents - administration & dosage | Remission Induction | Sulfonamides - pharmacokinetics | Dose-Response Relationship, Drug | Disease-Free Survival | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Tumor Lysis Syndrome - etiology | Antineoplastic Agents - adverse effects | Aged, 80 and over | Sulfonamides - adverse effects | Adult | Female | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Aged | Antineoplastic Agents - pharmacokinetics | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Sulfonamides - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - pharmacokinetics | Antimitotic agents | Treatment outcome | Care and treatment | Usage | Safety and security measures | Lymphocytic leukemia | Analysis | Clinical trials | Dosage and administration | Antineoplastic agents | Pharmacokinetics | Risk factors | Flow cytometry | Chronic lymphatic leukemia | Cell survival | Leukemia | Minimal residual disease | Diarrhea | Chromosome deletion | Nausea | Lymphatic leukemia | Lymphoma | Patients | Proteins | Chemotherapy | Fludarabine | Clonal deletion | Lysis | Respiratory tract diseases | Lymphomas | Chromosome 17 | Neutropenia | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article